Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions
Brain and Central Nervous System Tumors | Chemotherapeutic Agent Toxicity | Cognitive/Functional Effects | Neurotoxicity | Psychosocial Effects of Cancer and Its Treatment | Radiation Toxicity | Therapy-related Toxicity
What is the purpose of this trial?
RATIONALE: Collecting information over time from a series of tests may help doctors develop effective tests to measure neuropsychological and behavioral function in young patients with cancer.
PURPOSE: This clinical trial is studying neuropsychological and behavioral testing in young patients with medulloblastoma or supratentorial primitive neuroectodermal tumor (PNET).
Participation Guidelines
- Age:
- 3 Years - 21 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Children's Oncology Group
National Cancer Institute (NCI) - Dates:
- September 2008
- Last Updated:
- April 10, 2012
- Study HIC#:
- 0909005708
Clinicaltrials.gov ID: NCT00772200
For more information about this trial, contact:
Investigator
Gary Kupfer, MD
Principal Investigator
